生血宁治疗缺铁性贫血的临床研究

Study on Treatment of Iron deficiency Anemia by Shengxuening

目的观察生血宁治疗缺铁性贫血的药效及对铁代谢平衡调节的分子机制。方法 1 0 0例缺铁性贫血患者随机分为生血宁治疗组和葡萄糖酸亚铁对照组各 5 0例 ,治疗组用生血宁 0 1 g ,每天 3次口服 ;对照组用葡萄糖酸亚铁 0 1 g ,每天 3次口服 ;均连续服用 3 0天。治疗前后各检测 1次血清铁 (Fe)、总铁结合力 (totalironbindingcapacity ,TIBC)、转铁蛋白饱和度 (transferrinsaturation ,TS)、铁蛋白 (serumferritin ,SF)、转铁蛋白 (transferrin ,Tf)、血清可溶性转铁蛋白受体 (solubletransferrinreceptor ,sTfR)、血常规 ,并进行中医气血两虚证候评分。结果治疗组总有效率为 92 %;表明生血宁能改善铁代谢 ,提高Fe、TS、SF ,降低TIBC、Tf、sTfR ;促进红细胞生成作用明显 ;尚能促进白细胞及血小板生成。对照组总有效率为 3 2 %。两组比较差异有显著性 (P <0 0 1 )。结论生血宁治疗缺铁性贫血及气血两虚证效果明显 ,能改善铁代谢 ,提高Fe、TS、SF ,降低TIBC、Tf、sTfR。

Objective To observe the therapeutic effect of Shengxuening (SXN) in treating iron deficiency anemia (IDA) and to explore its molecular mechanism on iron metabolism balance regulation. Methods Patients with IDA were randomly divided into the treated group and the control group, 50 in each group. They were treated with SXN (0.1 g, three times per day) and ferrous gluconate (0.1 g, three times per day) respectively, for 30 days. Levels of serum iron (Fe), total iron binding capacity (TIBC), transferrin saturation (TS), serum ferritin (SF), transferrin (Tf), soluble transferrin receptor (sTfR) and blood routine test, as well as scoring of TCM qi blood deficiency Syndrome were conducted before and after treatment. Results The total effective rate in the treated group reached 92%, it was shown that SXN could improve the iron metabolism, increase levels of Fe, TS, SF and reduce levels of TIBC, Tf, sTfR, it has obvious effect in promoting erythrocyte generation and could promote formation of leucocytes and platelets. The total effective rate in the control group was 32%, which was significantly lower than that in the treated group (P<0.01). Conclusion The effect of SXN in treating IDA and qi blood deficiency Syndrome is evident, it could improve the iron metabolism, increase levels of Fe, TS, SF and lower levels of TIBC, Tf, sTfR.